97510467
Jul 19, 2022
Pharmaceutical preparations namely, monoclonal antibodies, small molecules, nanobodies, small interfering ribonucleic acids (siRNAs), antisense oligonucleotides (ASOs), cell therapies, gene therapies/editors, epigenetic modulators, and protein degraders, namely, small molecule proteolysis-targeting chimera (PROTACs), all of the foregoing for the treatment and prevention of aging and age-related diseases
Pharmaceuticals